Biomolecular NMR: a chaperone to drug discovery
- 5 May 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 10 (3) , 219-225
- https://doi.org/10.1016/j.cbpa.2006.04.006
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Ligand Docking in the Gastric H+/K+-ATPase: Homology Modeling of Reversible Inhibitor Binding SitesJournal of Medicinal Chemistry, 2005
- Structural basis for SUMO-E2 interaction revealed by a complex model using docking approach in combination with NMR dataProteins-Structure Function and Bioinformatics, 2005
- The dimer interface of the SARS coronavirus nucleocapsid protein adapts a porcine respiratory and reproductive syndrome virus‐like structureFEBS Letters, 2005
- TAR RNA Recognition by a Cyclic Peptidomimetic of Tat Protein,Biochemistry, 2005
- NMR in Pharmacokinetic and Pharmacodynamic ProfilingChemBioChem, 2005
- A peptide inhibitor of HIV-1 assembly in vitroNature Structural & Molecular Biology, 2005
- Solid-state NMR in drug design and discovery for membrane-embedded targetsNature Reviews Drug Discovery, 2005
- Using wavelet de-noised spectra in NMR screeningJournal of Magnetic Resonance, 2005
- Comparison of cell‐based and cell‐free protocols for producing target proteins from theArabidopsis thalianagenome for structural studiesProteins-Structure Function and Bioinformatics, 2005
- Application of NMR screening techniques for observing ligand binding with a protein receptorMagnetic Resonance in Chemistry, 2004